Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease

Silvia Andaloro,Fabrizio Mancuso,Luca Miele,Giovanni Addolorato,Antonio Gasbarrini,Francesca Romana Ponziani

DOI: https://doi.org/10.3390/nu16050613

IF: 5.9

2024-02-24

Nutrients

Abstract:Although alcohol is one of the most important etiologic agents in the development of chronic liver disease worldwide, also recognized as a promoter of carcinogenesis, several studies have shown a beneficial effect of moderate consumption in terms of reduced cardiovascular morbidity and mortality. Whether this benefit is also present in patients with liver disease due to other causes (viral, metabolic, and others) is still debated. Although there is no clear evidence emerging from guidelines and scientific literature, total abstention from drinking is usually prescribed in clinical practice. In this review, we highlight the results of the most recent evidence on this controversial topic, in order to understand the effect of mild alcohol use in this category of individuals. The quantification of alcohol intake, the composition of the tested populations, and the discrepancy between different works in relation to the outcomes represent important limitations emerging from the scientific literature. In patients with NAFLD, a beneficial effect is demonstrated only in a few works. Even if there is limited evidence in patients affected by chronic viral hepatitis, a clear deleterious effect of drinking in determining disease progression in a dose-dependent manner emerges. Poor data are available about more uncommon pathologies such as hemochromatosis. Overall, based on available data, it is not possible to establish a safe threshold for alcohol intake in patients with liver disease.

nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the impact of low - dose alcohol intake on patients with chronic liver diseases. Specifically, the study aims to analyze whether low - dose alcohol consumption has a positive or negative impact on patients who already have liver diseases caused by other etiologies (such as viral, metabolic or other reasons). Although previous studies have shown that moderate drinking can reduce the incidence and mortality of cardiovascular diseases, whether these benefits also apply to individuals with chronic liver diseases remains a controversial topic. Therefore, through reviewing the latest evidence, this review article aims to understand the effect of mild alcohol use in this specific population, in order to provide guidance for clinical practice.